VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PLXS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
PLXSPlexus Corp.
$287.44$7.7B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksPLXSFinancials

Plexus Corp. (PLXS) Financials

30Y historyFree accessUpdated daily

Revenue growth has accelerated to 18.7% in 2026Q2, though operating margins remain constrained at 5.3% due to the company's pass-through cost structure.

PLXS Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMSep'25Sep'24Sep'23Oct'22Oct'21Oct'20Sep'19Sep'18Sep'17Sep'16Sep'15Sep'14Sep'13Sep'12Sep'11Sep'10Sep'09Sep'08Sep'07Sep'06Sep'05Sep'04Sep'03Sep'02Sep'01Sep'00Sep'99Sep'98Sep'97Sep'96
Sales/Revenue4.31B4.03B3.96B4.21B3.81B3.37B3.39B3.16B2.87B2.53B2.56B2.65B2.38B2.23B2.31B2.23B2.01B1.62B1.84B1.55B1.46B1.23B1.04B807.84M883.6M1.06B751.64M492.41M396.81M386.43M316.12M
Revenue Growth %8.64%1.82%-5.93%10.47%13.14%-0.64%7.14%10.12%13.66%-1.09%-3.7%11.61%6.74%-3.41%3.38%10.82%24.54%-12.22%19.1%5.87%18.85%18.06%28.85%-8.57%-16.82%41.33%52.64%24.09%2.69%22.24%11.67%
Cost of Goods Sold3.88B3.63B3.58B3.82B3.46B3.05B3.08B2.87B2.62B2.27B2.33B2.41B2.15B2.01B2.09B2.02B1.81B1.46B1.64B1.38B1.3B1.12B954.08M754.87M802.28M930.51M644.48M426M346.87M342.42M288.79M
COGS % of Revenue-89.92%90.44%90.63%90.89%90.4%90.78%90.78%91.04%89.88%91.1%90.97%90.52%90.43%90.47%90.38%89.72%90.43%88.83%89.42%89.13%91.4%91.66%93.44%90.8%87.59%85.74%86.51%87.41%88.61%91.35%
Gross Profit433.38M406.51M378.53M394.55M347.23M323.3M312.71M291.84M257.6M255.85M227.36M239.55M225.57M213.19M219.91M214.74M206.92M154.78M205.76M163.54M158.7M105.74M86.78M52.97M81.32M131.79M107.16M66.41M49.95M44.02M27.33M
Gross Margin %10.05%10.08%9.56%9.37%9.11%9.6%9.22%9.22%8.96%10.12%8.9%9.03%9.48%9.57%9.53%9.62%10.28%9.57%11.17%10.58%10.87%8.6%8.34%6.56%9.2%12.41%14.26%13.49%12.59%11.39%8.65%
Gross Profit Growth %-7.39%-4.06%13.63%7.4%3.39%7.15%13.29%0.68%12.53%-5.09%6.2%5.81%-3.06%2.41%3.78%33.69%-24.78%25.82%3.05%50.09%21.85%63.84%-34.87%-38.3%22.98%61.37%32.96%13.47%61.04%1.61%
Operating Expenses210.36M204.14M210.8M198.73M169.04M147.03M159.33M149.78M139.32M125.95M120.89M122.42M113.68M116.56M115.75M113.56M107.27M93.14M100.81M82.26M78.44M76.32M68.26M65.15M72.38M59.87M36.16M25.46M19.02M17.2M13.35M
OpEx % of Revenue-5.06%5.32%4.72%4.44%4.36%4.7%4.73%4.85%4.98%4.73%4.61%4.78%5.23%5.02%5.09%5.33%5.76%5.47%5.32%5.37%6.21%6.56%8.06%8.19%5.64%4.81%5.17%4.79%4.45%4.22%
Selling, General & Admin210.36M199.46M190.54M175.64M167.02M143.76M153.33M148.1M139.32M125.95M120.89M122.42M113.68M116.56M115.75M113.56M107.27M93.14M100.81M82.26M78.44M76.32M68.26M65.15M66.92M55.84M35.05M26.44M19.02M17.2M13.35M
SG&A % of Revenue-4.95%4.81%4.17%4.38%4.27%4.52%4.68%4.85%4.98%4.73%4.61%4.78%5.23%5.02%5.09%5.33%5.76%5.47%5.32%5.37%6.21%6.56%8.06%7.57%5.26%4.66%5.37%4.79%4.45%4.22%
Research & Development0000000000000000000000000000000
R&D % of Revenue-------------------------------
Other Operating Expenses04.68M20.26M23.09M2.02M3.27M6M1.68M0451K000-642K00000000005.45M4.02M1.11M-984K000
Operating Income223.02M202.37M167.73M195.82M178.19M176.27M153.37M142.06M118.28M129.91M99.44M115.44M100.61M96.62M104.16M101.18M99.65M61.64M104.95M81.28M80.26M29.42M18.52M-12.19M8.95M71.92M71M38.98M36.39M34.43M13.32M
Operating Margin %5.17%5.02%4.23%4.65%4.68%5.23%4.52%4.49%4.12%5.14%3.89%4.35%4.23%4.34%4.52%4.53%4.95%3.81%5.7%5.26%5.5%2.39%1.78%-1.51%1.01%6.77%9.45%7.92%9.17%8.91%4.21%
Operating Income Growth %-20.65%-14.34%9.9%1.09%14.93%7.97%20.1%-8.95%30.64%-13.86%14.74%4.12%-7.24%2.95%1.53%61.67%-41.27%29.12%1.26%172.84%58.85%251.96%-236.24%-87.56%1.3%82.12%7.12%5.71%158.53%7.4%
EBITDA261.34M280.16M245.58M265.58M240.87M237.28M210.06M194.26M166.58M175.24M146.85M163.81M148.47M146.1M153.37M148.21M139.8M96.11M134.16M107.86M103.57M53.31M43.97M14.95M45.55M101.81M87.31M48.98M44.77M39.99M16.97M
EBITDA Margin %6.06%6.95%6.2%6.31%6.32%7.04%6.2%6.14%5.8%6.93%5.75%6.17%6.24%6.56%6.65%6.64%6.94%5.94%7.29%6.98%7.09%4.34%4.22%1.85%5.15%9.58%11.62%9.95%11.28%10.35%5.37%
EBITDA Growth %-2.12%14.08%-7.53%10.26%1.51%12.96%8.13%16.62%-4.94%19.33%-10.35%10.33%1.62%-4.74%3.49%6.01%45.47%-28.37%24.38%4.14%94.29%21.24%194.14%-67.18%-55.26%16.61%78.26%9.41%11.94%135.65%8.78%
D&A (Non-Cash Add-back)38.87M77.79M77.85M69.76M62.69M61.01M56.69M52.21M48.3M45.33M47.41M48.38M47.86M49.48M49.21M47.03M40.15M34.47M29.22M26.59M23.31M23.89M25.45M27.14M36.6M29.89M16.31M9.99M8.37M5.56M3.65M
EBIT220.17M199.62M158.41M192.56M174.16M174.66M151.56M138.81M119.84M135.4M102.03M120.26M111.89M97.62M107.3M99.44M95.12M56.29M104.95M81.28M80.26M29.42M18.52M-12.19M8.95M71.92M71M38.98M36.39M34.43M13.32M
Net Interest Income-7.61M-7.68M-25.02M-28.4M-14.55M-12.88M-14.28M-10.9M-7.53M-8.54M-10.39M-10.46M-9.36M-11M-14.3M-10.28M-8.15M-8.55M0000000000000
Interest Income3.61M3.92M3.86M3.14M1.3M1.37M1.88M1.95M4.7M5.04M4.24M3.5M2.93M1.64M1.76M1.37M1.44M2.32M0000000000000
Interest Expense11.22M11.61M28.88M31.54M15.86M14.25M16.16M12.85M12.23M13.58M14.63M13.96M12.29M12.64M16.06M11.65M9.59M10.88M0000000000000
Other Income/Expense-14.61M-14.35M-38.2M-34.81M-19.88M-15.86M-17.98M-16.1M-10.67M-8.09M-12.04M-9.14M-7.28M-11.64M-12.93M-9.08M-9.21M-16.22M-2.33M2.98M3.09M-40.41M-10.91M-59.54M-14.77M-6.56M-2.37M-2.84M0-3.51M-940K
Pretax Income208.41M188.02M129.53M161.01M158.3M160.41M135.4M125.95M107.61M121.82M87.39M106.3M93.33M84.98M91.23M92.1M90.44M45.42M102.61M84.25M83.35M-11M7.61M-71.72M-5.83M65.37M68.63M36.15M37.28M30.91M12.38M
Pretax Margin %4.84%4.66%3.27%3.82%4.15%4.76%3.99%3.98%3.74%4.82%3.42%4%3.92%3.81%3.96%4.13%4.49%2.81%5.57%5.45%5.71%-0.9%0.73%-8.88%-0.66%6.15%9.13%7.34%9.4%8%3.92%
Income Tax20.87M15.13M17.72M21.92M20.06M21.5M17.92M17.34M94.57M9.76M10.97M11.96M6.11M2.72M29.14M2.85M904K-908K18.47M18.54M-17.18M1.42M39.19M-27.23M-1.75M26.22M28.43M15.84M14.35M12.02M4.95M
Effective Tax Rate %10.02%8.05%13.68%13.61%12.67%13.4%13.23%13.77%87.88%8.01%12.55%11.25%6.55%3.21%31.94%3.09%1%-2%18%22%-20.61%-12.9%514.93%37.96%30.09%40.11%41.43%43.81%38.48%38.89%39.96%
Net Income187.54M172.88M111.81M139.09M138.24M138.91M117.48M108.62M13.04M112.06M76.43M94.33M87.21M82.26M62.09M89.26M89.53M46.33M84.14M65.72M100.03M-12.42M-31.58M-67.98M-4.07M39.15M40.2M20.31M22.94M18.89M7.43M
Net Margin %4.35%4.29%2.82%3.3%3.63%4.12%3.47%3.43%0.45%4.43%2.99%3.55%3.67%3.69%2.69%4%4.45%2.87%4.57%4.25%6.85%-1.01%-3.03%-8.41%-0.46%3.69%5.35%4.12%5.78%4.89%2.35%
Net Income Growth %31.42%54.62%-19.61%0.62%-0.48%18.24%8.16%732.94%-88.36%46.63%-18.98%8.16%6.02%32.49%-30.44%-0.31%93.26%-44.94%28.04%-34.3%905.55%60.68%53.54%-1568.99%-110.4%-2.6%97.9%-11.45%21.4%154.25%17.95%
Net Income (Continuing)187.54M172.88M111.81M139.09M138.24M138.91M117.48M108.62M13.04M112.06M76.43M94.33M87.21M82.26M62.09M89.26M89.53M46.33M84.14M65.72M100.53M-12.42M-31.58M-44.5M-4.07M39.15M40.2M20.31M22.94M18.89M7.43M
Discontinued Operations0000000000000000000000000000000
Minority Interest0000000000000000000000000000000
EPS (Diluted)6.856.264.014.954.864.763.933.500.383.242.242.742.522.361.752.302.191.171.921.412.15-0.29-0.74-1.61-0.100.911.040.280.370.270.17
EPS Growth %33.07%56.11%-18.99%1.85%2.1%21.12%12.29%821.05%-88.27%44.64%-18.25%8.73%6.78%34.86%-23.91%5.02%87.18%-39.06%36.17%-34.42%841.38%60.81%54.04%-1556.38%-110.68%-12.5%271.43%-24.32%37.04%58.82%13.33%
EPS (Basic)-6.394.085.044.964.864.023.590.403.332.292.812.582.401.782.342.241.181.941.422.22-0.29-0.74-1.61-0.100.951.120.300.390.290.17
Diluted Shares Outstanding27.37M27.62M27.91M28.11M28.44M29.17M29.92M31.07M33.92M34.55M34.1M34.38M34.66M34.89M35.53M38.8M40.83M39.65M43.85M46.74M46.49M43.37M42.89M42.28M41.9M43.23M38.73M74.04M61.53M62.31M42.5M
Basic Shares Outstanding26.76M27.04M27.4M27.58M27.86M28.57M29.2M30.27M33M33.61M33.37M33.62M33.78M34.33M34.87M38.06M40.05M39.41M43.34M46.31M45.15M43.37M42.89M42.28M41.9M41.13M36.03M69.29M59.32M55.95M42.5M
Dividend Payout Ratio-----------------------------1.79%6.94%

Key Metrics

Growth RegimeAccelerating
ProfitabilityModerate
Balance SheetHealthy
Cash FlowImproving
Top Statement Risk

Manufacturing capacity utilization volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Revenue Growth Accelerating Through Diversification

According to recent financial disclosures, Plexus achieved a notable 18.7% year-over-year revenue growth in 2026Q2, marking a significant departure from the stagnant or negative growth trends observed throughout the 2024 fiscal year and early 2025 periods, suggesting successful execution of its high-mix, low-volume manufacturing strategy.

The recent acceleration suggests that the company's focus on regulated end-markets like MedTech and Aerospace is beginning to yield tangible volume gains. Investors should monitor whether this growth is sustainable or if it reflects a temporary surge in project-based demand that may normalize in subsequent quarters.

Structural Constraints Limit Margin Expansion

As reported in quarterly income statements, Plexus maintains a gross margin hovering near 10%, a figure that has remained remarkably consistent despite the recent revenue acceleration, indicating that the company's cost structure is heavily tied to pass-through material expenses and competitive pricing pressures.

The inability to significantly expand gross margins despite higher revenue suggests that the company lacks substantial pricing power in its core EMS business. This structural limitation implies that profitability gains must come from operational efficiencies rather than premium product positioning.

Operating Leverage Remains Highly Sensitive

Based on the provided income statement data, operating margins have shown modest improvement to 5.3% in 2026Q2, demonstrating that Plexus is successfully scaling its fixed overhead costs as production volumes increase across its global manufacturing footprint in the Americas and Southeast Asia.

The sensitivity of operating income to revenue fluctuations highlights the company's reliance on high capacity utilization to drive bottom-line growth. If demand in the industrial sector softens, the company may face rapid deleveraging, which warrants close attention from risk-focused investors.

Earnings Quality Supported by Discipline

Analysis of recent filings reveals that Plexus has effectively managed its earnings profile, with net income reaching $49.8 million in 2026Q2, supported by a disciplined approach to operating expenses and a notable absence of significant non-operating charges that often distort performance in the EMS industry.

The reported EPS growth of 29.1% in the most recent quarter appears to be driven by core operational performance rather than accounting anomalies. However, investors should continue to scrutinize the impact of stock-based compensation, which can fluctuate and potentially mask the true cost of engineering talent retention.

Cyclical Risks Threaten Growth Narrative

While recent growth figures appear robust, a critical examination of the income statement suggests that Plexus remains vulnerable to cyclical downturns in its industrial and communications segments, which could quickly erode the modest margin gains achieved during the current period of increased manufacturing activity.

Short-sellers might focus on the company's reliance on project-based revenue, which lacks the predictability of true recurring service models. If the current momentum in the Healthcare segment fails to offset potential weakness in other areas, the company's valuation multiple may face significant downward pressure.

PLXS — Frequently Asked Questions

Quick answers to the most common questions about buying PLXS stock.

What was Plexus Corp.'s (PLXS) revenue in 2025?

For fiscal year 2025, Plexus Corp. (PLXS) reported total revenue of $4.03B. This represents a 1175.8% increase compared to $316.1M in 1996.

Is Plexus Corp. (PLXS) profitable?

Plexus Corp. (PLXS) is profitable, generating $172.9M in net income for the fiscal year ending 2025 with a net profit margin of 4.3%.

What is Plexus Corp.'s operating profit margin?

Plexus Corp. (PLXS) reported an operating income of $202.4M, resulting in an operating profit margin of 5.0%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Plexus Corp.'s gross profit and gross margin?

Plexus Corp. (PLXS) generated $406.5M in gross profit for the year, representing a gross profit margin of 10.1%. This demonstrates the company's core pricing power and production efficiency.